or Try an Advanced Search...

    Inflammatory Stocks List

    Symbol Grade Name % Change
    XOMA B XOMA Corporation 0.60
    OKYO C OKYO Pharma Limited -3.60
    ALDX D Aldeyra Therapeutics, Inc. 3.78
    PLUR D Pluri Inc. -3.06
    THAR D Tharimmune, Inc. 4.40
    APGE F Apogee Therapeutics, Inc. -2.35
    FRTX F Fresh Tracks Therapeutics -2.72
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Immunology Antibodies Uveitis Antibody Autoimmune Disease Disease Life Sciences Medicine Monoclonal Antibodies Solid Tumors Acne Acute Respiratory Distress Syndrome Allergic Conjunctivitis Allergy Antibody Product Atopic Dermatitis Biopharmaceutical Botulism Cancer Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Inflammatory stocks.

    Symbol Grade Name Weight
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.4
    DWAS B PowerShares DWA SmallCap Technical Leaders Portfolio 0.29
    IBB D iShares Nasdaq Biotechnology Index Fund 0.21
    SBIO C ALPS Medical Breakthroughs ETF 0.17
    IWC B iShares Microcap ETF 0.11
    View all Inflammatory ETFs...
    Compare ETFs
    Compare IBB to IWC Compare IBB to SBIO Compare QQQS to IBB

        Inflammatory Stocks Recent News

        Date Stock Title
        Nov 19 ALDX ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 18 ALDX Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 THAR Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
        Nov 18 APGE Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
        Nov 18 ALDX Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement
        Nov 15 OKYO MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
        Nov 15 PLUR Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Immunology Antibodies Uveitis Antibody Autoimmune Disease Disease Life Sciences Medicine Monoclonal Antibodies Solid Tumors Acne Acute Respiratory Distress Syndrome Allergic Conjunctivitis Allergy Antibody Product Atopic Dermatitis Biopharmaceutical Botulism Cancer Immunotherapy
        Inflammatory

        Browse All Tags